Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. BAJAJHFL:I
9. CCHGY
10. PRY:IM

Go back to Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings
StemCells, Inc. (NASDAQ: TEM) Delayed: 60.27 -1.33 (2.16%)
Previous Close $61.60    52 Week High $0.45 
Open $61.10    52 Week Low $0.37 
Day High $63.10    P/E N/A 
Day Low $58.91    EPS $-0.31 
Volume 5,966,545